Leslie Boyer, MD, is the founding Director of the VIPER Institute. She is the Principal Investigator for the multicenter scorpion antivenom clinical studies program conducted throughout Arizona, including protocols for placebo-controlled, double-blind trials, open-label studies, historical control studies, and the statewide STING project. She has coordinated phase 2 and phase 3 multicenter clinical trials of pit viper antivenom, developed the Antivenom Index, and participated in the establishment of the Pan-American Lymphotoxinology Taskforce.
Designated a Regents Professor of Biology in 2008, Dr. Sissom teaches in the Department of Life, Earth, and Environmental Sciences. His course responsibilities include: General Biology, Zoology, Entomology, Arthropods and Public Health, Invertebrate Zoology, Parasitology, Arachnology, Principles of Systematics, Graduate Seminars, Zoogeography, and Marine Biology.
Dr. Seibold is a veterinary emergency and critical care clinician and practice owner of Veterinary Urgent Care, Inc. in Escondido California.
Dr. Chippaux is a physician at the French Institute of Research for Development (IRD). While a medical student, he established a snake farm at the Institut Pasteur of Cote d'Ivoire to study snake venom, biology and taxonomy of snakes, and snakebites. He has been posted in Africa from 1985 to 2005, then in Bolivia. He published more than 250 scientific articles on tropical diseases, half of which concerned snakes or snakebites.
Dr. Witte is Professor of Surgery in the College of Medicine at The University of Arizona in Tucson, Arizona. She pioneered the international development of the discipline of lymphology (both clinical and basic), which incorporates the integrated workings of the lymphatic system's major components (lymphatics, lymph, lymph nodes, and lymphocytes) in health and disease.
Dr. Stock is a Senior Research Scientist and Group Leader in the Department of Molecular Medicine and Bioprocesses at the Instituto de Biotecnologia, Universidad Nacional Autónoma de México (UNAM) in Cuernavaca, Morelos, Mexico.
RESEARCH INTERESTS of the Stock lab.
1- Immunochemistry of venoms of mostly African snakes of medical importance, particularly elapids from the genera Naja (cobras) and Dendroaspis (mambas). We are interested in determining the minimum number of venoms of a given genus necessary to produce antivenoms with a maximum spectrum of therapeutic usefulness.
2- Cell biology of the parasite Entamoeba histolytica. We are interested in determining the factors that impinge on the cytolytic capacity of this common human intestinal pathogen. Our strategy has mostly relied on gene targetting and suppression by peptide nucleic acids and microscopic observation of sub-cellular compartments involved in protein trafficking.
3- Identification of antimicrobial agents in the venom of several species of snake.
4- Characterization of the biophysics of the action of sphingomyelinase D from several species of spiders of genus Loxosceles by, mostly, biophotonic and calorimetric approaches on model membranes.
5- Generation of recombinant active α-latrotoxins from different species of black widow spiders (genus Latrodectus).
Dr. Sevcik is Professor Emeritus, with the status of PLI (Active in research work) at the Centro de Biofisica y Bioquimica, Institute Venezolano de Investigaciones Cientificas (IVIC) in Caracas, Venezuela. Through his association with Mexico's Institute of Biotechnology, he lends his expertise in pharmacokinetics to VIPER's US-Mexico alliance.
Dr. Ruha is Director of the Medical Toxicology fellowship program at Banner Good Samaritan Medical Center in Phoenix, Arizona.